ENvue Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 14

Employees

  • Stock Symbol
  • FEED

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.26
  • (As of Thursday Closing)

ENvue General Information

Description

ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.

Contact Information

Website
www.envuemed.com
Formerly Known As
NanoVibronix
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 762 West Algonquin Road
  • Arlington Heights, IL 60005
  • United States
+1 (800)
Primary Industry
Therapeutic Devices
Stock Exchange
OTCM
Corporate Office
  • 762 West Algonquin Road
  • Arlington Heights, IL 60005
  • United States
+1 (800)

ENvue Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ENvue Stock Performance

As of 12-Nov-2026, ENvue’s stock price is $0.26. Its current market cap is $240K with 924K shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.26 $0.26 $0.12 - $73.08 $240K 924K 49.2K -$339.36

ENvue Financials Summary

As of 30-Jun-2026, ENvue has a trailing 12-month revenue of $1.93M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,112 (1,266) 1,034 (1,415)
Revenue 1,926 2,553 2,558 2,283
EBITDA (25,554) (21,992) (3,581) (3,546)
Net Income (21,063) (18,185) (3,705) (3,711)
Total Assets 38,405 41,124 3,629 6,674
Total Debt 1,310 1,197 116 5
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ENvue Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ENvue‘s full profile, request access.

Request a free trial

ENvue Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions
Therapeutic Devices
Arlington Heights, IL
14 As of 2025

Tirat Carmel, Israel
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ENvue Competitors (2)

One of ENvue’s 2 competitors is Insightec, a Venture Capital-Backed company based in Tirat Carmel, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Insightec Venture Capital-Backed Tirat Carmel, Israel
Convatec Group Formerly PE-Backed London, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

ENvue Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

ENvue Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130030329-A1 Apparatus and methods for friction reduction Inactive 11-Jan-2010
US-7829029-B2 Uses surface sound waves of rayleigh-lamb and/or love type to prevent adhesion of bacteria to catheter, preventing urinary tract infection, irritation Active 29-Mar-2006
US-20070244423-A1 Acoustic add-on device for biofilm prevention in urinary catheter Active 29-May-2002
US-20050038376-A1 Method, apparatus and system for treating biofilms associated with catheters Active 29-May-2002
US-7393501-B2 Vibrating a piezo element attached to the catheter surface in a combination of vibrational modes to cause a combination of acoustic wave modes including surface rayleigh or lamb waves; vibrations are amplified by resonance in the catheter balloon generating vibrations in exiting liquid and surface waves Inactive 29-May-2002 A61L2/02
To view ENvue’s complete patent history, request access »

ENvue Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ENvue Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ENvue‘s full profile, request access.

Request a free trial

ENvue Acquisitions (1)

ENvue’s most recent deal was a Merger/Acquisition with ENvue Medical (Acquired). The deal was made on 14-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ENvue Medical (Acquired) 14-Feb-2025 Merger/Acquisition Medical Supplies
To view ENvue’s complete acquisitions history, request access »

ENvue ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

39.27 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view ENvue’s complete esg history, request access »

ENvue Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
ENvue Medical (Acquired) Arlington Heights, IL 2019

ENvue FAQs

  • When was ENvue founded?

    ENvue was founded in 2003.

  • Where is ENvue headquartered?

    ENvue is headquartered in Arlington Heights, IL.

  • What is the size of ENvue?

    ENvue has 14 total employees.

  • What industry is ENvue in?

    ENvue’s primary industry is Therapeutic Devices.

  • Is ENvue a private or public company?

    ENvue is a Public company.

  • What is ENvue’s stock symbol?

    The ticker symbol for ENvue is FEED.

  • What is the current stock price of ENvue?

    As of 12-Nov-2026 the stock price of ENvue is $0.26.

  • What is the current market cap of ENvue?

    The current market capitalization of ENvue is $240K.

  • What is ENvue’s current revenue?

    The trailing twelve month revenue for ENvue is $1.93M.

  • Who are ENvue’s competitors?

    Insightec and Convatec Group are competitors of ENvue.

  • What is ENvue’s annual earnings per share (EPS)?

    ENvue’s EPS for 12 months was -$339.36.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process